Declaration Partners

Varo Bank

San Francisco

Varo is an entirely new kind of bank. All digital, mission driven, FDIC insured and designed for the way our customers live their lives. We’re working toward our mission with a team that uniquely and strategically combines banking veterans with technology experts. The banking experts provide decades of industry experience, and the tech experts can build a mobile app that offers everyone access to premium banking, including quicker access to your money, high-yield savings, and automatic saving tools. Varo has raised over $992.4m to date, from leading institutional investors and strategic partners including Warburg Pincus, The Rise Fund, Gallatin Point Capital, Harbourvest Partners, Progressive Insurance, Russell Westbrook Enterprises, and Lone Pine Capital. Varo. Varo. A bank for all of us.

Synthego

Menlo Park

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Amperity

Seattle

Amperity is an Intelligent Customer Data Platform that empowers global consumer brands by unlocking all their customer data.

Redesign health

New York

Redesign Health is a venture builder enabling founders to launch and scale transformative healthcare companies. Since 2018 it has launched 60+ ventures, reaching 15M patients and $1B in revenue, with Mayo Clinic and Cedars Sinai advisory bo

ResortPass

New York

ResortPass provides day access to hotel amenities without overnight stays, partnering with 2,000+ hotels (Ritz-Carlton, Four Seasons, Westin, Fairmont) and connecting 5M+ locals and visitors. It has raised a $40M Series B led by Declaration

GN Group

Shakopee

Jabra Hearing's mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.

Anomaly

New York

Anomaly streamlines healthcare payments for providers, payers, and patients to reduce costs and complexity, serving the country’s largest healthcare companies. It has a fast-growing team and announced $17 million in Series A and seed fundin

ConcertAI

Cambridge

ConcertAI is an AI-powered SaaS data company that develops medical research tools in oncology.